These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38369695)

  • 1. A contactless cure: Leveraging telehealth to improve hepatitis C treatment at a safety-net hospital.
    Frye K; Davis A; Darby R; McDaniel K; Quairoli K; Liu Z; Miller LS; Fluker SA
    J Viral Hepat; 2024 Apr; 31(4):176-180. PubMed ID: 38369695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Large-Scale, Primary Care-Based Hepatitis C Treatment in an Urban, Medically Underserved Patient Population.
    Fluker SA; Darby R; McDaniel K; Quairoli K; Mbonu C; Kilakkathi S; Koumtouzoua S; Jagannathan R; Miller LS
    Public Health Rep; 2024; 139(2):163-168. PubMed ID: 37232166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized controlled trial for a peer-facilitated telemedicine hepatitis c treatment intervention for people who use drugs in rural communities: study protocol for the "peer tele-HCV" study.
    Herink MC; Seaman A; Leichtling G; Larsen JE; Gailey T; Cook R; Thomas A; Korthuis PT
    Addict Sci Clin Pract; 2023 May; 18(1):35. PubMed ID: 37245041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of the COVID-19 pandemic on hepatitis C outcomes at a health-system specialty pharmacy.
    Cooper MP; Foley H; Damico D; Wright M; Rhudy C; Schadler A; Platt T
    J Manag Care Spec Pharm; 2022 Jun; 28(6):667-672. PubMed ID: 35621721
    [No Abstract]   [Full Text] [Related]  

  • 5. Hepatitis C treatment outcomes among patients treated in co-located primary care and addiction treatment settings.
    Ngo BV; James JR; Blalock KL; Jackson SL; Chew LD; Tsui JI
    J Subst Abuse Treat; 2021 Dec; 131():108438. PubMed ID: 34098298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A nurse-led, telehealth-driven hepatitis C management initiative in regional Victoria: Cascade of care from referral to cure.
    Rodrigues B; Parsons N; Haridy J; Bloom S; Day C; Haar G; Nicoll A; Sawhney R
    J Telemed Telecare; 2024 Apr; 30(3):497-504. PubMed ID: 34142898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of treatment access and scope of a multistate hepatitis C virus Extension for Community Healthcare Outcomes telehealth service in the US Indian Health System, 2017-2021.
    Wirth AN; Cushman NA; Reilley BA; Leston JD; Mera JR; Levander XA; Stephens DJ
    J Rural Health; 2023 Mar; 39(2):358-366. PubMed ID: 36526593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postpartum Hepatitis C Linkage to Care Program in a Co-located Substance Use Disorders Treatment Model.
    Cheedalla A; Hinely K; Roby L; Hall OT; Malvestutto C; Rood KM
    Matern Child Health J; 2023 Dec; 27(Suppl 1):87-93. PubMed ID: 37768533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient-centered HCV care via telemedicine for individuals on medication for opioid use disorder: Telemedicine for Evaluation, Adherence and Medication for Hepatitis C (TEAM-C).
    Talal AH; Markatou M; Sofikitou EM; Brown LS; Perumalswami P; Dinani A; Tobin JN
    Contemp Clin Trials; 2022 Jan; 112():106632. PubMed ID: 34813962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of telehealth to increase treatment access for prisoners with chronic hepatitis C.
    Halder A; Li VG; Sebastian M; Nazareth S; Tuma R; Cheng W; Doyle A
    Intern Med J; 2021 Aug; 51(8):1344-1347. PubMed ID: 34423535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of Pharmacist-Led Treatment of Hepatitis C in the Virginia Department of Corrections.
    Masuda QN; Smith JE; Gaines J; Dillingham RA
    J Correct Health Care; 2023 Dec; 29(6):430-438. PubMed ID: 37943532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glecaprevir/pibrentasvir for 8 weeks in treatment-naïve patients with chronic HCV genotypes 1-6 and compensated cirrhosis: The EXPEDITION-8 trial.
    Brown RS; Buti M; Rodrigues L; Chulanov V; Chuang WL; Aguilar H; Horváth G; Zuckerman E; Carrion BR; Rodriguez-Perez F; Urbánek P; Abergel A; Cohen E; Lovell SS; Schnell G; Lin CW; Zha J; Wang S; Trinh R; Mensa FJ; Burroughs M; Felizarta F
    J Hepatol; 2020 Mar; 72(3):441-449. PubMed ID: 31682879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utilizing Telemedicine and Modified Fibrosis Staging Protocols to Maintain Treatment Initiation and Adherence Among Hepatitis C Patients During the COVID-19 Pandemic.
    O'Brien M; Daws R; Amin P; Lee K
    J Prim Care Community Health; 2022; 13():21501319221108000. PubMed ID: 35748428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of e-Health in Optimizing Task-Shifting in the Delivery of Antiviral Therapy for Chronic Hepatitis C.
    Yoo ER; Perumpail RB; Cholankeril G; Jayasekera CR; Ahmed A
    Telemed J E Health; 2017 Oct; 23(10):870-873. PubMed ID: 28375820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HCV hotline facilitates Hepatitis C elimination during the COVID-19 pandemic.
    Hartl L; Jachs M; Bauer D; Simbrunner B; Chromy D; Binter T; Steininger L; Schwarz C; Schwarz M; Burghart L; Strassl R; Trauner M; Gschwantler M; Mandorfer M; Reiberger T
    J Viral Hepat; 2022 Dec; 29(12):1062-1072. PubMed ID: 36062398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of Hepatitis C virus among people who inject drugs at a syringe service program during the COVID-19 response: The potential role of telehealth, medications for opioid use disorder and minimal demands on patients.
    Sivakumar A; Madden L; DiDomizio E; Eller A; Villanueva M; Altice FL
    Int J Drug Policy; 2022 Mar; 101():103570. PubMed ID: 34954493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct Acting Antivirals Improve HCV Treatment Initiation and Adherence Among Underserved African Americans.
    Beck KR; Kim NJ; Khalili M
    Ann Hepatol; 2018; 17(3):413-418. PubMed ID: 29735789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using telehealth to improve access to hepatitis C treatment in the direct-acting antiviral therapy era.
    Schulz TR; Kanhutu K; Sasadeusz J; Watkinson S; Biggs BA
    J Telemed Telecare; 2020 Apr; 26(3):180-185. PubMed ID: 30336724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Providing Hepatitis C Treatment Locally for Substance-Using Patients.
    Clapp SB; Johnson CB
    J Prim Care Community Health; 2023; 14():21501319231186355. PubMed ID: 37424381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Collaborative Referral Model for Hepatitis C Screening and Treatment in a Remote Mountainous Region of Taiwan during the COVID-19 Pandemic.
    Tai CM; Bair MJ; Chen TH; Tseng CH; Chen CC; Lam H; Yu ML
    Viruses; 2023 Mar; 15(4):. PubMed ID: 37112808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.